Recorded live webinar on December 12, 2017.
Emerging evidence of the use of glycomacropeptide (GMP) based products in the dietary management of PKU has generated interest in its potential benefits. Long-term efficacy studies and use in individuals under the age of 11 are lacking. The speakers will present the latest research from an ongoing, long term study being conducted in the UK. This is the first long term clinical trial including children from the age of 5 – 16 years with PKU, comparing a group using a GMP based medical food as part of dietary management with a group taking an amino acid based medical food. Data presented will include, impact on metabolic control, growth and nutritional status.
Speakers: Elissaveta Johnson, Professor Anita MacDonald, PhD, BSc, OBE, Anne Daly, MS, BSc, RD, and Rachel Coode.
GMP in PKU - The Latest Research from Vitaflo USA on Vimeo.